Colgate-Palmolive reported its second-quarter earnings for 2025, surpassing analyst expectations with an adjusted earnings per share (EPS) of $0.92 compared to the estimated $0.90. The company posted total sales of $5.11 billion, exceeding the projected $5.03 billion. The reported EPS stood at $0.91. For the full fiscal year, Colgate-Palmolive projects organic sales growth between 2% and 4%, with non-GAAP EPS expected to increase in the low single digits. The company also announced the launch of a three-year productivity program designed to support its 2030 strategic goals, noting that substantially all charges related to this program will be incurred during the year. Following the earnings release, Colgate-Palmolive’s shares showed a positive pre-market movement.